Importantly, a more in depth understanding of the roles played by Bcl-3 in immune pathologies could, in time, encourage the therapeutic targeting of this important regulator of NF-κB as a way of controlling autoimmune disease and other immunopathologies. The gene discussed is NFKB1; the disease is autoimmune disease.